Advertisement
Screener

VISTAGEN THERAPEUTICS, INC. (VTGN) Other Non-Current Assets

2.8 / 5 stars · 68/120 Roast Me

VISTAGEN THERAPEUTICS, INC. Other Non-Current Assets

VISTAGEN THERAPEUTICS, INC. (VTGN) had Other Non-Current Assets of $392.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.

Financial Statements › Balance Sheet › Assets › Assets, Noncurrent

us-gaap:OtherAssetsNoncurrent · last filed 2026-08-14

  • 2026-06-30: Other Assets, Noncurrent $392.00K.
  • 2026-03-31: Other Assets, Noncurrent $393.00K.
  • 2025-12-31: Other Assets, Noncurrent $392.00K.
  • 2025-09-30: Other Assets, Noncurrent $405.00K.
Period endOther Assets, NoncurrentOther Assets, Noncurrent as first filed
2026-06-30$392.00K
10-Q · filed 2026-08-14
2026-03-31$393.00K
10-Q · filed 2026-08-14
2025-12-31$392.00K
10-Q · filed 2026-02-12
2025-09-30$405.00K
10-Q · filed 2025-11-13
2025-06-30$472.00K
10-Q · filed 2025-08-07
2025-03-31$454.00K
10-K · filed 2026-06-15
2024-12-31$477.00K
10-Q · filed 2025-02-13
2024-09-30$498.00K
10-Q · filed 2024-11-07
2024-06-30$518.00K
10-Q · filed 2024-08-13
2024-03-31$726.00K
10-K · filed 2025-06-17
2020-12-31$47.80K
10-Q · filed 2021-02-11
2020-09-30$47.80K
10-Q · filed 2020-11-12
2020-06-30$47.80K
10-Q · filed 2020-08-13
2020-03-31$47.80K
10-Q · filed 2021-02-11
2019-12-31$47.80K
10-Q · filed 2020-02-13
2019-09-30$47.80K
10-Q · filed 2019-11-07
2019-06-30$47.80K
10-Q · filed 2019-08-13
2019-03-31$47.80K
10-Q · filed 2020-02-13
2018-12-31$47.80K
10-Q · filed 2019-02-12
2018-09-30$47.80K
10-Q · filed 2018-10-29
2018-06-30$47.80K
10-Q · filed 2018-08-14
2018-03-31$47.80K
10-Q · filed 2019-02-12
2017-12-31$47.80K
10-Q · filed 2018-02-12
2017-09-30$47.80K
10-Q · filed 2017-11-09
2017-06-30$47.80K
10-Q · filed 2017-08-14
2017-03-31$47.80K
10-Q · filed 2018-02-12
2016-12-31$47.80K
10-Q · filed 2017-02-13
2016-09-30$47.80K
10-Q · filed 2016-11-14
2016-06-30$46.90K
10-Q · filed 2016-08-12
2016-03-31$46.90K
10-Q · filed 2017-02-13
2015-12-31$46.90K
10-Q · filed 2016-02-16
2015-09-30$46.90K
10-Q · filed 2015-11-16
2015-06-30$46.90K
10-Q · filed 2015-08-14
2015-03-31$46.90K
10-Q · filed 2016-02-16
2014-12-31$46.90K
10-Q · filed 2015-02-17
2014-09-30$46.90K
10-Q · filed 2014-11-19
2014-06-30$46.90K
10-Q · filed 2014-08-12
2014-03-31$46.90K
10-K · filed 2015-06-29
2013-12-31$46.90K
10-Q · filed 2014-02-14
2013-09-30$46.90K
10-Q · filed 2013-11-14
2013-06-30$29.00K
10-Q · filed 2013-08-14
2013-03-31$46.90K
10-Q · filed 2014-11-19
$29.00K
10-K · filed 2013-07-18
2012-12-31$29.80K
10-Q · filed 2013-02-14
2012-09-30$29.00K
10-Q · filed 2012-11-14
2012-06-30$29.00K
10-Q · filed 2012-08-14
2012-03-31$29.00K
10-Q · filed 2013-11-14
2011-12-31$31.14K
10-Q · filed 2012-02-14
2011-09-30$31.14K
10-Q · filed 2011-11-14
2011-06-30$31.14K
10-Q · filed 2011-08-22
2011-03-31$31.10K
10-K · filed 2012-07-02
$31.14K
10-Q · filed 2011-08-22

Similar stocks

Stock NameCountryMarket CapPE Ratio
MUSTANG BIO, INC. (MBIO)United States$0.013B
AEON Biopharma, Inc. (AEON)United States$0.013B-0.36
LISATA THERAPEUTICS, INC. (LSTA)United States$0.014B-2.13
Tempest Therapeutics, Inc. (TPST)United States$0.013B
Aspire Biopharma Holdings, Inc. (ASBP)United States$0.012B-0.60
BIOVIE INC. (BIVI)United States$0.012B
BullFrog AI Holdings, Inc. (BFRG)United States$0.014B
ADIAL PHARMACEUTICALS, INC. (ADIL)United States$0.012B
Vyome Holdings, Inc (HIND)United States$0.014B-1.38
Tvardi Therapeutics, Inc. (TVRD)United States$0.014B